$179.95
+0 (+0%)
At Close: Jun 23, 2026
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
09:47am, Friday, 09'th Dec 2022
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
Masimo (MASI) W1 Watch With Hi to Improve Patient Outcome
05:06pm, Thursday, 08'th Dec 2022 Zacks Investment Research
Masimo's (MASI) full-market release of the Hi for the Masimo W1 watch is likely to significantly improve RPM.
Masimo (MASI) W1 Watch With Hi to Improve Patient Outcome
01:33pm, Thursday, 08'th Dec 2022
Masimo's (MASI) full-market release of the Hi for the Masimo W1 watch is likely to significantly improve RPM.
Masimo (MASI) Announces Positive Study Results on PBM by SpHb
05:33pm, Monday, 05'th Dec 2022 Zacks Investment Research
Masimo's (MASI) SpHb is likely to enhance transfusion management and post-operative patient outcomes on patients.
Masimo (MASI) Announces Positive Study Results on PBM by SpHb
02:18pm, Monday, 05'th Dec 2022
Masimo's (MASI) SpHb is likely to enhance transfusion management and post-operative patient outcomes on patients.
Expert Ratings for Masimo
01:03pm, Monday, 05'th Dec 2022 Benzinga
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
1
2
0
0
Last 30D
7 Analysts Have This to Say About Masimo
12:02pm, Monday, 05'th Dec 2022 Benzinga
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
1
2
0
0
Last 30D
Is Masimo a Good Deal as the CEO Loads Up on Shares?
03:49pm, Friday, 25'th Nov 2022
The CEO of Masimo Corporation ( MASI , Financial) recently bought a significant number of his company's shares. According to the GuruFocus CEO Buys screener, Joe Kiani bought 39,778 shares of his comp
Over $17 Million Bet On Element Solutions? Check Out These 3 Stocks Insiders Are Buying
01:38pm, Wednesday, 16'th Nov 2022 Benzinga
Although US stocks closed higher on Tuesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
Masimo (MASI) Q3 Earnings Top Estimates, 2022 View Revised
03:38pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q3 sales.
6 Analysts Have This to Say About Masimo
02:34pm, Wednesday, 09'th Nov 2022 Benzinga
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
2
0
0
Last 30D
0
0
Masimo (MASI) Q3 Earnings Top Estimates, 2022 View Revised
12:02pm, Wednesday, 09'th Nov 2022
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q3 sales.
Masimo (MASI) Q3 Earnings and Revenues Surpass Estimates
10:55pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Masimo (MASI) delivered earnings and revenue surprises of 8.70% and 2.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo Corporation (MASI) Q3 2022 Earnings Call Transcript
08:40pm, Tuesday, 08'th Nov 2022
Masimo Corporation (NASDAQ:MASI ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Eli Kammerman – Vice President-Business Development and Investor Relations Joe Kia
Masimo (MASI) Q3 Earnings and Revenues Surpass Estimates
07:33pm, Tuesday, 08'th Nov 2022
Masimo (MASI) delivered earnings and revenue surprises of 8.70% and 2.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sign In
Buy MASI